XXXVIII
Congreso de la Sociedad Española de Inmunología Clínica, Alergología y Asma Pediátrica
63
9.
Tabar AI, Anda M, Bonifazi F, Biló MB, Ley-
nadier F, Fuchs T, Ring J, Galvain S, André
C. Specific immunotherapy with standar-
dized latex extract versus placebo in latex-
allegic patients. Int Arch Allergy Immunol
2006;141:369-376.
10. Patriarca G, Nucera E, Pollastrini E, Ron-
callo C, Buonomo A, Bartolozzi F, De Pas-
quale T, Gabarrini G, Schiavino D. Sub-
lingual desensitization: a new aproach to
latex allergy problem. Anesth Analg 2002;
95:956-60.
11. CisteróA, Sastre J, Enrique E, Fernández M,
Alonso R, Quirce S, Gandarias B, Parmiani
S, Rico P.Tolerance and effects on skin reac-
tivity to latex of sublingual rush immuno-
therapy with a latex extract. J Invest Aller-
gol Clin Immunol 2004;14(1):17-25.
12. Bernardini R, Campodonico P, Burastero
S, Azzari C, Novembre E, Pucci N, et al. Su-
blingual immunotherapy with a latex ex-
tract in paediatric patients: a double-blind,
placebo-controlled study. Curr Med Res
Opin 2006; 22:1515-22.
13. Sanz ML, García-Avilés MC, Tabar AI, et
al. Basophil ActivationTest an specific IgE
measurementes using a panel of recom-
binant natural rubber latex allergens to
determine the latex allergen sensitization
profile in children. Pediatr Allergy Immu-
nol 2006;17:148-156.
14. Lasa E, Tabar AI,GarcÎa BE, Anda M, Sanz
ML, Raulf-Heimsoth, M , Barber D. Compo-
nent-resolved immunologicmodifications,
efficacy, and tolerance of latex sublingual
immunotherapy in children. Ann Allergy
Asthma Immunol 2012, 108 367–372
15. Krishna MT, Ewan PW, Diwakar L, Durham
SR, FrewAJ, Leech SC, Nasser SM. Diagno-
sis and management of hymenoptera ven-
om allergy: British Society for Allergy and
Clinical Immunology (BSACI) guidelines.
Clin Exp Allergy. 2011 Sep;41(9):1201-20.
16. Brown TC, Tankersley MS. The sting
of the honeybee: an allergic perspec-
tive. Ann Allergy Asthma Immunol. 2011
Dec;107(6):463-70.
17. Treudler R, Simon JC. Overview of Com-
ponent Resolved Diagnostics. Curr Aller-
gy Asthma Rep. 2012 Oct ,18.
Los resultados preliminares apuntan hacia
la utilidad del Diagnóstico molecular en
la indicación y elección de tratamiento co-
rrecto en los pacientes alérgicos a venenos
de himenópteros.
Comentario y trabajo futuro
La posibilidad de la determinación de anti-
cuerpos IgE específicos frente a múltiples re-
combinantes o alergenos naturales purifica-
dos, cambia significativamente el diagnóstico
y tratamiento de las enfermedades alérgicas.
Bibliografía
1.
Ytalo L, Alenius H, Turjanmaa K, Palouso
T, Reunala T. IgE antibodies to prohevein,
hevein, and rubber elongation factor in
children with latex allergy. J Allergy Clin
Immunol 1998;102(Pt 1):659-64.
2.
Nieto A, Pamies R, Mazon A. Peculiarities
of latex allergy and preventive measures
in the pediatric age group. Allergol Immu-
nopathol 2002;30:148-56.
3.
Ytalo L, Alenius H, Turjanmaa K, Palouso
T, Reunala T. IgE antibodies to prohevein,
hevein, and rubber elongation factor in
children with latex allergy. J Allergy Clin
Immunol 1998;102(Pt 1):659-64.
4.
Ebo DG, Hagendorens MM, De Knop KJ,
et al. Component-resolved diagnosis from
latex allergy by microarray. Clin Exp Al-
lergy 2010;40:348-358.
5.
Pereira C, Rico P, Lourenco M, Lombardero
M, Pinto-Mendes J, Chieira C. Specific im-
munotherapy for occupational latex aller-
gy. Allegy 1999;55:291-293.
6.
Leynadier F, Herman D, Vervloet D, Andre
C. Specific immunotherapy with standar-
dized latex extract versus placebo in aller-
gic healthcare workers. J Allergy Clin Im-
munol 2000;106:585-90.
7.
Sastre J, Fernández-Nieto M, Rico P, Martín
S, Barber D, Cuesta J, De las HerasM, Quirce
S. Specific immunotherapy with a standard-
ized latex extract in allergic workers: A dou-
ble-blind, placebo-controlled study. J Aller-
gy Clin Immunol 2003;111:985-993.
8.
Pereira C, Pedro E, Tavares B, Ferreira MB,
Carrapatoso I, Rico P, et al. Specific immu-
notherapy for severe latex allergy. Eur Ann
Allergy Clin Immunol 2003;35:217-225.
